Hennigsdorf, Germany · Founded 2009 · Privately Held (backing)
Developer of clinical-stage pharmaceutical products designed to improve vascular integrity. Adrenomed is based in Hennigsdorf, Germany and was founded in 2009. Its last reported valuation was $134 million in Mar 2021. It has raised $61.3 million.
Last reported valuation
$133.9M
Oct 2026
Priced at
—
Total raised
$61.3M
Last round
—
Cap table — not yet on record
Adrenomed's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Adrenomed with a free account
·Watch Adrenomed: the Monday email on marks, rounds and moves
